Track: Cardio Oncology
As cancer survival rates improve, cardiovascular toxicity from cancer therapies has emerged as a leading cause of morbidity and mortality among cancer survivors. The Cardiac Oncology session examines the mechanisms and surveillance strategies for anthracycline cardiomyopathy, immune checkpoint inhibitor-associated myocarditis, HER2-targeted therapy cardiotoxicity, radiation-induced coronary artery disease and constrictive pericarditis, and androgen deprivation therapy cardiovascular effects. The session will present the 2022 ESC Cardio-Oncology Guidelines framework, baseline and on-treatment cardiac surveillance protocols, cardioprotective therapy with ACE inhibitors, beta-blockers, and SGLT2 inhibitors, and the organisational models for integrated cardio-oncology service delivery.
Key Discussion Areas:
- Anthracycline cardiomyopathy: mechanisms, surveillance, and cardioprotective strategies
- Immune checkpoint inhibitor myocarditis: diagnosis, grading, and management
- HER2-targeted therapy cardiotoxicity: trastuzumab and pertuzumab cardiac monitoring
- Radiation-induced heart disease: coronary disease, pericarditis, and valvulopathy
- Androgen deprivation therapy and cardiovascular risk in prostate cancer
- Baseline and on-treatment cardiac surveillance: echocardiography, GLS, and biomarkers
- Cardioprotective pharmacotherapy: ACE inhibitors, beta-blockers, and SGLT2 inhibitors
- Cardio-oncology service models: integrated multidisciplinary care pathways
Why Attend This Session?
Cardiologists, oncologists, haematologists, radiation oncologists, and cardiac imaging specialists will gain practical frameworks for baseline risk assessment, on-treatment cardiac monitoring, cardiotoxicity management, and the integration of cardio-oncology services into comprehensive cancer care programmes.
Related Topics:
- Heart Failure & Cardiomyopathies
- Cardiac Imaging & Advanced Diagnostics
- Hypertension & Hypertensive Heart Disease
- Preventive Cardiology
- Electrophysiology & Arrhythmia Management
Frequently Asked Questions:
1.What is the importance of cardio oncology in cardiovascular medicine?
Cardio Oncology plays a significant role in improving diagnosis, treatment strategies, patient outcomes, and clinical decision-making in modern cardiology.
2.What are the latest trends in cardio oncology?
Recent trends include precision medicine, AI-assisted diagnostics, minimally invasive therapies, digital healthcare technologies, and personalized patient management.
Scientific Highlights
- Preventive Cardiology and Cardiovascular Risk Reduction
- Heart Failure and Advanced Cardiac Therapies
- Interventional Cardiology and Structural Heart Disease
- Cardiac Electrophysiology and Arrhythmia Management
- Acute Coronary Syndromes
- Cardiovascular Imaging and Multimodality Diagnostics
- Cardiomyopathies: Genetics, Phenotyping, and Treatment
- Cardio Oncology
- Cardiometabolic Disease, Lipidology, and Atherosclerosis
- Hypertension and Renal Cardiovascular Interactions
- Digital Health, AI, and the Future of Cardiology
- Pediatric and Congenital Cardiology
- Vascular Medicine and Aortic Diseases
- Women's Cardiovascular Health and Sports Cardiology
- Precision Medicine, Genomics, and Regenerative Cardiology
- Cardiovascular and Cardiothoracic Surgery
- Cardiovascular Case Studies and Clinical Insights
- Emergency and Critical Cardiac Care
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Conference Enquiry - Kristina Pierce
kristinapierce@scientexconferences.com
General Enquiry
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
cardiacsurgery@scientexevents.org
Our Social Presence
Call us at
USA : (+1) 272 374 1068